X

pharmaceuticals

Pfizer Inc. (PFE) Q2 2021 Earnings Call

Pfizer Inc. (NYSE: PFE) Q2 2021 Earnings call dated Jul. 28, 2021 Corporate Participants: Christopher Stevo — Senior Vice President, Chief Investor Relations…

Infographic: How Pfizer (PFE) performed in Q2 2021

Pfizer Inc. (NYSE: PFE) reported second quarter 2021 earnings results today. Total revenue increased 92% year-over-year to $19 billion. GAAP…

IPO Alert: What to look for when Ocean Biomedical goes public

After tech start-ups, the biotechnology industry is keeping the IPO market busy nowadays. It is estimated that Wall Street is…

Abbott Laboratories ease past street targets: Infographic

Abbott Laboratories (NYSE: ABT) reported second-quarter 2021 financial results before the regular market hours on Thursday. The pharmaceutical giant reported…

Biogen (BIIB) Earnings Infographic: Q2 profit, revenue drop but top estimates

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Thursday said its second-quarter earnings and revenues decreased from last year. The results, however,…

Johnson & Johnson beats in Q2; raises FY guidance

Johnson & Johnson (NYSE: JNJ) reported second-quarter 2021 financial results before the regular market hours on Wednesday. The pharmaceutical giant…

Absci IPO: Here’s all you need to know about bioengineering firm’s Nasdaq listing

Wall Street is probably going through the busiest phase since the recession, in terms of the number of businesses seeking…

IPO News: Should you invest in Sight Sciences’ initial public offering?

The continuing stock market rally, at a time when the pandemic-hit economy is struggling to regain strength, has set off…

Aerovate Therapeutics IPO: What awaits the biotech firm after market debut?

The IPO market has continued the bull run so far this year, unfazed by the virus-related uncertainties, with the technology…

Context Therapeutics: Another clinical-stage oncology research firm to go public soon

The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in…

Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?

The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for…

IPO News: What to look for when Elevation Oncology makes its Wall Street debut

The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that…

Trxade Health Inc. (NASDAQ: MEDS) Q2 2021 Research Summary

Trxade Health Inc. (NASDAQ: MEDS), a health services IT company, plays a key role in ensuring the availability of healthcare…

Is Merck (MRK) stock still a buy after losing the vaccine race?

After bringing the global economy to a grinding halt, the coronavirus pandemic is subsiding in most regions, thanks to the…

LLY Stock: Is Eli Lilly a good bet in COVID-challenged healthcare market?

For pharmaceutical companies, 2020 was a busy year when the healthcare sector went into overdrive to deal with the challenges…

SmileDirectClub (SDC) bets on rapid telemedicine-adoption to drive growth

The adoption of telemedicine accelerated in recent months, especially after the pandemic-related shelter-in-place orders came into effect. The trend will…

SmileDirectClub (SDC) Q1 Report: Net loss narrows but misses estimates

Digital healthcare firm SmileDirectClub Inc. (NASDAQ: SDC) reported a narrower net loss for the first quarter of 2021 amid modest…

Pfizer, Inc. (PFE) Q1 2021 Earnings Call Transcript

Pfizer, Inc. (NYSE: PFE) Q1 2021 earnings call dated May. 04, 2021 Corporate Participants: Charles E. Triano -- Senior Vice President, Investor…

Pfizer (PFE) reports Q1 EPS of 93 cents: Infographic

Pfizer (NYSE: PFE) reported first-quarter 2021 financial results ahead of the regular market hours on Tuesday. The pharmaceutical giant reported…

AbbVie (ABBV) Stock: Here’s what you need to know before investing

AbbVie Inc. (NYSE: ABBV) has long been fighting to delay the entry of generic alternatives to Humira, the pharma giant's…

Vertex Pharmaceuticals Inc (VRTX) Q1 2021 Earnings Call Transcript

Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Q1 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Michael Partridge -- Senior Vice President of…